[go: up one dir, main page]

ES2108566T3 - Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos. - Google Patents

Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos.

Info

Publication number
ES2108566T3
ES2108566T3 ES95905357T ES95905357T ES2108566T3 ES 2108566 T3 ES2108566 T3 ES 2108566T3 ES 95905357 T ES95905357 T ES 95905357T ES 95905357 T ES95905357 T ES 95905357T ES 2108566 T3 ES2108566 T3 ES 2108566T3
Authority
ES
Spain
Prior art keywords
patient serum
allergen
pct
host cells
ige
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95905357T
Other languages
English (en)
Inventor
Wai Fei David Tai
John Lowe
Paula Jardieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2108566T3 publication Critical patent/ES2108566T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PROPORCIONAN TAMBIEN METODOS PARA DIAGNOSTICO DE UNA ENFERMEDAD ALERGICA EN UN PACIENTE. SE PROPORCIONAN TAMBIEN METODOS DE INVESTIGACION DE PRODUCTOS TERAPEUTICOS ANTI-ALERGICOS Y ANTAGONISTAS IGE.
ES95905357T 1993-12-10 1994-12-09 Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos. Expired - Lifetime ES2108566T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16543693A 1993-12-10 1993-12-10

Publications (1)

Publication Number Publication Date
ES2108566T3 true ES2108566T3 (es) 1997-12-16

Family

ID=22598886

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95905357T Expired - Lifetime ES2108566T3 (es) 1993-12-10 1994-12-09 Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos.

Country Status (10)

Country Link
US (1) US5714338A (es)
EP (1) EP0733207B1 (es)
JP (1) JP3507852B2 (es)
AT (1) ATE157455T1 (es)
CA (1) CA2176811C (es)
DE (1) DE69405251T2 (es)
DK (1) DK0733207T3 (es)
ES (1) ES2108566T3 (es)
GR (1) GR3025089T3 (es)
WO (1) WO1995016203A2 (es)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526599D0 (en) * 1995-12-28 1996-02-28 Sandoz Ltd Elisa test system
DE19643427C1 (de) * 1996-10-22 1998-02-12 Bundesrep Deutschland Verfahren zur Bestimmung von Allergenen in der Luft
US6165799A (en) * 1996-12-10 2000-12-26 Heska Corporation Detection of anti-Fc.sub.ε R autoantibodies in asthmatics
US7122636B1 (en) 1997-02-21 2006-10-17 Genentech, Inc. Antibody fragment-polymer conjugates and uses of same
US6060326A (en) * 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
FR2765341A1 (fr) * 1997-06-25 1998-12-31 Alain Funes Methode pour l'analyse de l'activation des basophiles humains par mesure de l'expression membranaire du marqueur cd63
AU1727500A (en) * 1998-11-17 2000-06-05 Tanox, Inc. Bispecific molecules cross-linking itim and itam for therapy
WO2001051076A1 (en) * 2000-01-14 2001-07-19 Tanox, Inc. ADMINISTERING IgE ANTAGONISTS DURING PREGNANCY TO AMELIORATE ALLERGIC DISEASES IN THE OFFSPRING
US6889145B1 (en) 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
RU2195666C2 (ru) * 2000-09-13 2002-12-27 Амурская государственная медицинская академия Способ комплексной диагностики аллергии у детей с инфекционной патологией
EP1195606A1 (en) * 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-microarray assay
DE10110838C2 (de) * 2001-03-06 2003-04-03 Mlu Halle Wittenberg Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen
FR2831186B1 (fr) * 2001-10-22 2004-06-18 Aventis Pharma Sa Production d'heparine a partir de cultures de mastocytes
WO2003066662A2 (en) 2002-02-05 2003-08-14 Genentech, Inc. Protein purification
DK1501369T3 (en) 2002-04-26 2015-09-28 Genentech Inc Non-affinity purification of proteins
LT3095793T (lt) 2003-07-28 2020-07-10 Genentech, Inc. Baltymo a išplovimo sumažinimas afininės baltymo a chromatografijos metu
US7613619B1 (en) * 2004-03-30 2009-11-03 Harter Michael R Method for identifying allergens and other influencing agents that may cause a reaction
US7662926B2 (en) * 2004-09-02 2010-02-16 Genentech, Inc. Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
ZA200701783B (en) * 2004-09-02 2009-10-28 Genentech Inc Anti-Fc-gamma RIIB receptor antibody and uses therefor
US7655229B2 (en) * 2004-09-02 2010-02-02 Chan Andrew C Anti-FC-gamma RIIB receptor antibody and uses therefor
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
US7977063B2 (en) * 2005-03-16 2011-07-12 N.V. Nutricia Method for determining an allergic response
US20070117217A1 (en) * 2005-06-16 2007-05-24 The Regents Of The University Of California Large scale parallel immuno-based allergy test and device for evanescent field excitation of fluorescence
US20080011058A1 (en) * 2006-03-20 2008-01-17 The Regents Of The University Of California Piezoresistive cantilever based nanoflow and viscosity sensor for microchannels
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
CN101542285B (zh) * 2006-12-01 2015-11-25 国立血清研究所 使用吸附于滤纸上的样品的筛选方法
WO2008079280A1 (en) * 2006-12-21 2008-07-03 Millipore Corporation Purification of proteins
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
ES2426158T3 (es) 2007-01-22 2013-10-21 Genentech, Inc. Precipitación con polielectrolito y purificación de anticuerpos
US8191403B2 (en) * 2007-03-27 2012-06-05 Richmond Chemical Corporation Petroleum viscosity measurement and communication system and method
EP2188302B1 (en) 2007-07-09 2017-11-01 Genentech, Inc. Prevention of disulfide bond reduction during recombinant production of polypeptides
PL2840090T3 (pl) 2007-10-30 2018-07-31 Genentech, Inc. Oczyszczanie przeciwciał za pomocą chromatografii kationowymiennej
WO2009151514A1 (en) * 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor
PT3604324T (pt) 2008-08-14 2024-05-10 Genentech Inc Métodos para remover um contaminante com a utilização de cromatografia de membrana de permuta iónica de deslocação de proteína indígena
EP2334323A2 (en) 2008-09-10 2011-06-22 F. Hoffmann-La Roche AG Compositions and methods for the prevention of oxidative degradation of proteins
EP2370561B1 (en) 2008-12-16 2019-08-07 EMD Millipore Corporation Stirred tank reactor and method
JP2012512244A (ja) 2008-12-16 2012-05-31 イー・エム・デイー・ミリポア・コーポレイシヨン タンパク質の精製
WO2010099273A1 (en) 2009-02-27 2010-09-02 Genentech, Inc. Methods and compositions for protein labelling
US10184937B2 (en) * 2009-03-31 2019-01-22 United Arab Emirates University Minimally invasive assessment of IgE mediated allergy
DE102009030845A1 (de) * 2009-06-26 2010-12-30 Siemens Aktiengesellschaft Verfahren und Kit zur Diagnose oder Prognose einer Kontrastmittelallergie
MX355650B (es) 2009-08-11 2018-04-26 Genentech Inc Produccion de proteinas en medios de cultivo de celulas libres de glutamina.
US9428548B2 (en) 2009-09-01 2016-08-30 Genentech, Inc. Enhanced protein purification through a modified protein A elution
JP5937059B2 (ja) 2010-03-22 2016-06-22 ジェネンテック， インコーポレイテッド タンパク質含有製剤の安定化に有用な組成物及び方法
MX2012012743A (es) 2010-05-03 2012-11-23 Genentech Inc Composiciones y metodos utiles para reducir la viscosidad de formulaciones que contienen proteina.
KR101551295B1 (ko) 2010-05-17 2015-09-08 이엠디 밀리포어 코포레이션 생체분자 정제용 자극 반응성 중합체
WO2011150241A2 (en) 2010-05-28 2011-12-01 Genentech, Inc. Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
MY184736A (en) 2010-06-24 2021-04-20 Genentech Inc Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
BR112013003279A2 (pt) 2010-08-13 2016-06-14 Genentech In “métodos para tratar uma doença, método para neutralizar ou bloquear a atividade de il-1ß e/ou il-18, anticorpo, usos de um anticorpo e usos de um anticorpo monoclonal”
WO2012030512A1 (en) 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
KR101949187B1 (ko) 2011-07-08 2019-04-22 이엠디 밀리포어 코포레이션 일회용 생명공학적 공정용의 개선된 심층 필터
RU2648999C2 (ru) 2011-12-22 2018-03-29 Дженентек, Инк. Способы повышения эффективности этапов очистки белка, находящихся ниже по потоку, с использованием мембранной ионообменной хроматографии
CA2866753C (en) 2012-03-27 2020-09-22 Genentech, Inc. Improved harvest operations for recombinant proteins
ES2682761T3 (es) 2012-05-18 2018-09-21 Genentech, Inc. Formulaciones de anticuerpos monoclonales de alta concentración
CN104994885B (zh) 2012-12-19 2017-09-29 基因泰克公司 用于放射性卤素蛋白质标记的方法和组合物
HRP20201663T1 (hr) 2014-07-09 2020-12-25 F. Hoffmann - La Roche Ag PRILAGOĐAVANJE pH VRIJEDNOSTI RADI POBOLJŠANJA OPORAVKA BANAKA STANICA USLIJED ODMRZAVANJA
JP2019510517A (ja) 2016-03-29 2019-04-18 ジェルター， インコーポレイテッド 細胞質内体積に対するペリプラズム体積の比率が０．５：１および１０：１の間にあるグラム陰性細菌におけるタンパク質の発現
WO2018119312A1 (en) 2016-12-22 2018-06-28 Genentech, Inc. Methods and formulations for reducing reconstitution time of lyophilized polypeptides
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
LT3818078T (lt) 2018-07-03 2024-04-25 Bristol-Myers Squibb Company Rekombinantinių baltymų gamybos būdas
KR20210074341A (ko) 2018-10-10 2021-06-21 베링거 인겔하임 인터내셔날 게엠베하 고밀도 생물 반응기 배양에서 막 기체 전달을 위한 방법
TWI856084B (zh) 2019-04-01 2024-09-21 美商建南德克公司 用於穩定含有蛋白質之配方之組合物及方法
JP7777451B2 (ja) 2019-04-12 2025-11-28 ジェルター， インコーポレイテッド 組換えエラスチンおよびその産生
CN114514311A (zh) 2019-08-01 2022-05-17 百时美施贵宝公司 改进补料分批细胞培养物中蛋白质产量的方法
CN116194570A (zh) 2020-09-22 2023-05-30 百时美施贵宝公司 用于产生治疗性蛋白的方法
CN113495139A (zh) * 2021-07-07 2021-10-12 上海清芮科技有限公司 一种宠物特应性体质的检测方法
US20250115666A1 (en) 2021-08-05 2025-04-10 Bristol-Myers Squibb Company Cell culture methods for producing therapeutic proteins
WO2023049687A1 (en) 2021-09-21 2023-03-30 Bristol-Myers Squibb Company Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559310A (en) * 1983-05-20 1985-12-17 Dana Farber Cancer Institute Assay methods and systems utilizing mast cell clones
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
EP0248211B1 (en) * 1986-04-30 1992-03-11 Junji Yodoi Novel protein and a method for production thereof
US5180805A (en) * 1986-07-02 1993-01-19 Research Corporation Limited Polypeptide competitor for immunoglobulin E
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
JPH03127997A (ja) * 1989-10-11 1991-05-31 Kuraray Co Ltd ヒト１ｇＥ結合因子に特異的なモノクローン抗体、それを産生するハイブリドーマおよびその用途
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies
WO1993011437A1 (en) * 1991-12-05 1993-06-10 Board Of Regents Of The University Of Nebraska Allergen specific immunoglobulin-e producer test for diagnosing allergies
GB9224956D0 (en) * 1992-11-28 1993-01-20 Euro Dpc Ltd Improvements relating to allergen testing & apparatus

Also Published As

Publication number Publication date
DE69405251D1 (de) 1997-10-02
WO1995016203A2 (en) 1995-06-15
EP0733207A1 (en) 1996-09-25
EP0733207B1 (en) 1997-08-27
DK0733207T3 (da) 1998-04-20
DE69405251T2 (de) 1998-02-05
CA2176811C (en) 2008-01-29
CA2176811A1 (en) 1995-06-15
GR3025089T3 (en) 1998-01-30
ATE157455T1 (de) 1997-09-15
WO1995016203A3 (en) 1995-06-29
US5714338A (en) 1998-02-03
JPH09506435A (ja) 1997-06-24
JP3507852B2 (ja) 2004-03-15

Similar Documents

Publication Publication Date Title
ES2108566T3 (es) Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos.
McPherson et al. Henry's clinical diagnosis and management by laboratory methods E-book
Sanz et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate‐type reactions to betalactam antibiotics
Hogenelst et al. Ambulatory measurement of cortisol: Where do we stand, and which way to follow?
Mayxay et al. An assessment of the use of malaria rapid tests by village health volunteers in rural Laos
Lindemann et al. ELISpot: a new tool for the detection of nickel sensitization
Moore et al. Smartphone-based measurement of executive function in older adults with and without HIV
Popple et al. The lymphocyte transformation test in allergic contact dermatitis: new opportunities
Tanaka et al. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine‐secreting activity in T cells responding to allo‐stimulation
Firestone et al. Anxiety, fear, and affiliation with similar-state versus dissimilar-state others: Misery sometimes loves nonmiserable company.
Nicoll et al. The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom
Lushington et al. Are counseling students stressed? A cross-cultural comparison of burnout in Australian, Singaporean and Hong Kong counseling students
Halevy In vitro tests for adverse drug reactions based on cytokine release
Wu et al. Progenitor cell‐derived basophils: A novel barcoded passive degranulation assay in allergic diseases
Cunha et al. Sensitivity of indirect immunofluorescence and ELISA in detecting intercellular antibodies in endemic pemphigus foliaceus (Fogo Selvagem)
Fitzpatrick et al. Health care needs of Indochinese refugee teenagers
YOSHIMURA et al. Diagnosis of drug allergy by the lymphocyte stimulation test with the MTT [3-(4, 5-dimethyl thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide] assay
Nolte The clinical utility of basophil histamine release
French et al. The use of tetanus toxoid to elucidate the delayed-type hypersensitivity response in an older, immunized population
Grobusch et al. Sensitivity of P. vivax rapid antigen detection tests and possible implications for self-diagnostic use
Girsh et al. The diagnosis of drug allergies. Utilizing in vitro mast cell test and IgE inhibition test.
Zevon et al. Stress and coping relationships in the medical environment: A natural experiment
Medalia et al. Psychometric properties of the web-based work-readiness cognitive screen used as a neuropsychological assessment tool for schizophrenia
Nagel et al. Sequence Analysis of Cardiometabolic Multimorbidity and Association with Subsequent Dementia
Kuwabara et al. Comparison between ImmunoCAP and multiple antigen simultaneous tests for measuring Aspergillus-specific Immunoglobulin E levels in Aspergillus-sensitized patients

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 733207

Country of ref document: ES